MGMT Promoter Methylation Testing in Glioblastoma

Short answer: MGMT promoter methylation testing tells you whether the MGMT DNA-repair gene is silenced in a glioblastoma. Patients with a methylated MGMT promoter benefit more from temozolomide, so the result guides treatment, especially in older patients. Most labs test with bisulfite-based methods such as methylation-specific PCR (MSP) or pyrosequencing. Newer bisulfite-free qPCR, such as EpiDirect® MGMT, measures methylation directly in untreated DNA in about two hours on a standard real-time PCR instrument.

Last updated: November 2026

Why MGMT methylation status matters

MGMT (O6-methylguanine-DNA methyltransferase) repairs the DNA damage that alkylating chemotherapy such as temozolomide causes. When the MGMT promoter is methylated, the gene is switched off, the tumour cannot repair that damage, and the chemotherapy works better.

Because a “methylated” or “unmethylated” result changes treatment, the method needs to be reliable close to its cut-off, work on small FFPE biopsies, and fit the lab’s turnaround time.

MGMT testing methods compared

MethodDNA treatmentResultEquipmentTypical considerations
Methylation-specific PCR (MSP)Bisulfite conversionQualitative (methylated / unmethylated)PCR + gel or qPCRWidely used and inexpensive; interpretation of weak bands can be subjective
PyrosequencingBisulfite conversionQuantitative, per CpG sitePyrosequencerCommon reference method; cut-off varies between labs; dedicated platform
Methylation-specific digital PCRBisulfite conversionQuantitativeDigital PCR systemVery sensitive; dPCR platform needed
Methylation arrays (e.g. MGMT-STP27)Bisulfite conversionQuantitative scoreArray scannerOften done alongside methylation-based tumour classification; batch-based, several days
MS-MLPAMethylation-sensitive restriction enzymeSemi-quantitativeCapillary electrophoresisNo bisulfite; multi-step workflow
Bisulfite-free qPCR (EpiDirect® MGMT)NoneQuantitativeStandard real-time PCR instrumentAbout 2 hours; 0.5–50 ng input; CE-IVD under the IVDR

The problem with bisulfite conversion

Bisulfite treatment converts unmethylated cytosines so that methylated and unmethylated DNA can be told apart. It is also harsh: it fragments DNA and loses a large share of the input. That matters most for small or poorly preserved FFPE biopsies, and the extra conversion step adds hands-on time, cost and a source of variation between runs.

Bisulfite-free MGMT testing with EpiDirect®

EpiDirect® MGMT Methylation qPCR Assay measures MGMT promoter methylation directly in untreated genomic DNA. It is built on PentaBase’s INA® chemistry: an EpiPrimer™ binds and primes amplification of methylated DNA, while unmethylated DNA is not amplified. A reference reaction measures the total DNA, and the ratio gives the methylation level.

What the evidence shows

Bendixen et al., Nature Communications, 2023. The study introducing the EpiDirect technology compared EpiDirect MGMT with two bisulfite-based methylation-specific PCR assays on 42 FFPE brain tumour samples and reported high sensitivity and specificity. Read the paper.

Németh et al., Neuro-Oncology Advances, 2026. An independent group in Giessen and Heidelberg tested 35 FFPE IDH-wildtype glioblastomas with EpiDirect and four established or emerging methods: pyrosequencing, MGMT-STP27 from EPIC arrays, MSP and methylation-specific digital PCR. EpiDirect agreed with each method in 88.6–94.3% of cases (Cohen’s κ 0.77–0.89), with no significant directional bias, and all five assays gave the same classification in 30 of 35 tumours. The authors conclude that the results support analytical non-inferiority, and note that larger prospective studies with outcome data are still needed and that most disagreements were close to the assay cut-offs. Read the paper.

Close-to-cut-off disagreement is not specific to EpiDirect: it is seen between every pair of MGMT methods, and published pyrosequencing cut-offs themselves differ between labs.

Switching from pyrosequencing

Qiagen has announced that the last PyroMark CE-IVD therascreen® assays will be placed on the market by 26 May 2026, and that the therascreen® MGMT Pyro® Kit will be discontinued by 28 February 2027 or until stocks last. Labs that rely on it for MGMT testing need a validated replacement.

A typical switch to EpiDirect MGMT looks like this:

Contact us to plan a verification study, or ask for the IFU and performance data.

What does MGMT methylation testing cost?

The cost per patient sample depends on more than the kit price:

An EpiDirect® MGMT kit contains 48 reactions, including positive and negative controls and two MGMT methylation standards (3% and 10%) for the standard curve. Pricing depends on your region and volume. Request a quote or find your local distributor.

Frequently asked questions

What is MGMT promoter methylation?

It is the addition of methyl groups to the promoter region of the MGMT gene, which switches the gene off. Tumours with a methylated MGMT promoter cannot repair the DNA damage caused by temozolomide as well, so they respond better to it.

Which MGMT test is most accurate?

There is no single gold standard. Pyrosequencing, MSP, digital PCR, methylation arrays and bisulfite-free qPCR all agree for most tumours and disagree mainly for samples close to the cut-off. A quantitative method with a validated cut-off and a clear policy for borderline results matters more than the specific technology.

Can MGMT methylation be tested without bisulfite conversion?

Yes. EpiDirect® MGMT measures methylation directly in untreated DNA by qPCR, and MS-MLPA uses methylation-sensitive restriction enzymes instead of bisulfite.

How much DNA is needed?

EpiDirect® MGMT works with 0.5–50 ng of purified DNA from FFPE or fresh-frozen tumour tissue with at least 20% tumour cells. Bisulfite-based methods usually need more input because conversion degrades part of the DNA.

How long does an MGMT test take?

With EpiDirect® MGMT the qPCR run takes under 2 hours after DNA extraction. Bisulfite-based methods add a conversion step, and array-based testing is usually run in batches over several days.

What will replace the Qiagen therascreen MGMT Pyro kit?

Each lab chooses its own replacement. EpiDirect® MGMT is a CE-IVD, IVDR-certified alternative that targets CpG sites in the same part of MGMT exon 1 and runs on standard qPCR instruments, so it can be verified against existing pyrosequencing results without new equipment.